Background: Chronic viral hepatitis (CVH) is associated not only with progressive liver damage but also with disturbances in the hemostatic system, which can lead to an increased risk of bleeding and thrombotic events. Understanding these alterations is critical for optimizing patient management.

Chronic viral hepatitis, Hemostasis, Coagulation, Bleeding risk, Thrombosis, Platelet function, Liver disease, Clinical monitoring

Singh A. D., Mucha S. R., Lindenmeyer C. C. Cirrhotic coagulopathy: A rebalanced hemostasis. Cleveland Clinic Journal of Medicine. 2022;89(9):523533. DOI:10.3949/ccjm.89a.21018.

Islam R., Kundu S., Jha S. B. et al. Cirrhosis and coagulopathy: Mechanisms of hemostasis changes in liver failure and their management. Cureus. 2022;14(4):e23785. DOI:10.7759/cureus.23785.

Scharf R. E. Thrombocytopenia and hemostatic changes in acute and chronic liver disease: pathophysiology, clinical and laboratory features, and management. Journal of Clinical Medicine. 2021;10(7):1530. DOI:10.3390/jcm10071530.

Franchini M. Coagulation abnormalities in chronic liver disease. Seminars in Thrombosis and Hemostasis. 2025; (in press) DOI:10.1055/a-2531-4712.

Wahyuni W., Novita D. Hemostatic abnormalities in patients with liver cirrhosis: a review. Jurnal Kedokteran Diponegoro (Diponegoro Medical Journal). 2022;11(4). DOI:10.14710/dmj.v11i4.34158. ejournal3.undip.ac.id

Kurtov I. V., Davydkin I. L., Chairetdinov R. K. Disbalance of the hemostasis in patients with chronic hepatitis and hepatocirrhosis of viral etiology complicates thrombocytopenia. RUDN Journal of Medicine. 2010;3:139142. journals.rudn.ru

Wahba M. A., ElBassiouni N. E., Elsakhawy Y. N. ADAMTS13 and von Willebrand factor levels in patients with chronic hepatitis C: relations to hemostatic imbalance and bacterial infection. QJM: An International Journal of Medicine. 2023;116(Supplement_1). DOI:10.1093/qjmed/hcad069.192.

Northup P. G., Caldwell S. H. Abnormalities of hemostasis and bleeding in chronic liver disease: the paradigm is challenged. Hepatology. 2009;49(3):10171045. DOI:10.1002/hep.22735.

Kosnik A., et al. Comprehensive coagulation factor profiling in acuteonchronic liver failure: a stepwise progression of hemostatic imbalance. Polish Archives of Internal Medicine. 2024; (online ahead of print).

Lawson N. R. A review of extrahepatic manifestations in chronic hepatitis B and C infections. J Hepatol Gastroint Dis. 2025;11:352. DOI:10.35248/2475-3181.25.11.352.

Jumayeva M.F., Predictors of The Development Of Hepatorenal Syndrome. //Problems biology and medicine. 2022;6(140):80-82.

Jumaeva M.F., Hepatorenal Syndrome. //Asian journal of Pharmaceutical and biological research. SEPT.-DEC. 2022;11(3):72-77.

Jumayeva M.F. Hepatocardiorenal syndrome. //Asian journal of Pharmaceutical and biological research. JAN-APR 2022;11(1).

Lisman T.; Leebeek F.W.G. Hemostatic alterations in liver disease: A review on pathophysiology, clinical consequences, and treatment. //Dig. Surg. 2007;24:250-258.

Lisman T. Hemostatic dysfunction in liver diseases. //Semin. Thromb. Hemost. 2015;445-446.

Lisman T., Porte R.J. Rebalanced hemostasis in patients with liver disease: Evidence and clinical consequences. //Blood 2010;116:878-885.

Lisman T.; Bongers T.N., Adelmeijer J., Janssen H.L.A., de Maat, M.P.M., de Groot P.G., Leebeek F.W.G. Elevated levels of von willebrand factor in cirrhosis support platelet adhesion despite reduced functional capacity. //Hepatology 2006;44:53-61.

Tolibov F.F. - VIOLATION OF PLATELET AGGREGATION AND IMBALANCE OF HEMOSTASIS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS C//New Day in Medicine 6(68)2024 264-268 https://newdayworldmedicine.com/en/article/3758

Sherman K.E. Advanced liver disease: What every hepatitis c virus treater should know. //Top. Antivir. Med. 2011;19:121-125.

Tripodi A., Mannucci P.M. The coagulopathy of chronic liver disease. //N. Engl. J. Med. 2011;365:147-156.

Zampino R., Marrone A., Restivo L., Guerrera B., Sellitto A., Rinaldi L., Romano C., Adinolfi L.E. Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations. //World J. Hepatol. 2013;5:528-540.

Jumaeva M.F., Gepatokardiorenal sindrom. //Farmatsevtika va biologik tadqiqotlar Osiyo jurnali. 2022 YAN-APRAL;11(1):83-97.

Jumaeva MF, Gepatorenal sindrom. //Farmatsevtika va biologik tadqiqotlar Osiyo jurnali. SENTYABR-DEK. 2022;11(3):72-77.

Jumayeva MF, Gepatorenal sindrom rivojlanishining prognozchilari. //Biologiya va tibbiyot muammolari. 2022;6(140):80-82.